Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Feb 8:7:42226.
doi: 10.1038/srep42226.

CXCL12/CXCR4 axis induced miR-125b promotes invasion and confers 5-fluorouracil resistance through enhancing autophagy in colorectal cancer

Affiliations

CXCL12/CXCR4 axis induced miR-125b promotes invasion and confers 5-fluorouracil resistance through enhancing autophagy in colorectal cancer

Xinfeng Yu et al. Sci Rep. .

Abstract

The activation of CXCL12/CXCR4 axis is associated with potential progression of cancer, such as invasion, metastasis and chemoresistance. However, the underlying mechanisms of CXCL12/CXCR4 axis and cancer progression have been poorly explored. We hypothesized that miRNAs might be critical downstream mediators of CXCL12/CXCR4 axis involved in cancer invasion and chemoresistance in CRC. In human CRC cells, we found that the activation of CXCL12/CXCR4 axis promoted epithelial-mesenchymal transition (EMT) and concurrent upregulation of miR-125b. Overexpression of miR-125b robustly triggered EMT and cancer invasion, which in turn enhanced the expression of CXCR4. Importantly, the reciprocal positive feedback loop between CXCR4 and miR-125b further activated the Wnt/β-catenin signaling by targeting Adenomatous polyposis coli (APC) gene. There was a negative correlation of the expression of miR-125b with APC mRNA in paired human colorectal tissue specimens. Further experiments indicated a role of miR-125b in conferring 5-fluorouracil (5-FU) resistance in CRC probably through increasing autophagy both in vitro and in vivo. MiR-125b functions as an important downstream mediator upon the activation of CXCL12/CXCR4 axis that involved in EMT, invasion and 5-FU resistance of CRC. These findings shed a new insight into the role of miR-125b and provide a potential therapeutic target in CRC.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interests.

Figures

Figure 1
Figure 1. CXCL12 induced upregulation of miR-125b and concurrent EMT in CRC cells.
(A) HCT116 and SW620 cells were exposed to 100 ng/μl CXCL12 for the indicated time. RT-qPCR was performed to determine the expression of miR-125b. (B) HCT116 cells were transfected with 200 nM siRNA of CXCR4 or expression plasmid together with corresponding controls for 48 h. RT-qPCR was performed to determine the expression of miR-125b. (CE) The cells were treated as indicated above by CXCL12, the mRNA levels of E-cadherin, vimentin and CXCR4 were determined by RT-qPCR assay. *P < 0.05 vs. control. (F) The protein level of E-cadherin, vimentin and CXCR4 was examined by Western blot assay.
Figure 2
Figure 2. Overexpression of miR-125b promoted EMT in CRC cells.
(A,B) HCT116 and SW620 cells were transfected with 100 nM miR-125b mimics (125 m) or inhibitors (125i) for 48 h. The levels of miR-125b were determined by RT-qPCR assay. (C,D) The cells were treated as indicated above, the mRNA levels of E-cadherin, vimentin and CXCR4 were determined by RT-qPCR assay. (E) The levels of ZEB1, Snail, vimentin and E-cadherin were determined by Western blot assay. Bar graphs indicated the relative levels of the proteins normalized to β-actin. *P < 0.05 vs. negative control. (F) HCT116 and SW620 cells were transfected with 100 nM miR-125b mimics (125 m) or inhibitor (125i) for 24 h, then were treated with or without 100 ng/μl CXCL12 for 24 h. The capacity of cell invasion was evaluated by transwell assay. *P < 0.05 vs. negative control (NC). #P < 0.05 vs. NC and 125i groups, respectively.
Figure 3
Figure 3. MiR-125b enhanced cell invasion by targeting APC gene.
(A) HCT116 and SW620 cells were transfected with 100 nM miR-125b mimics (125 m) or inhibitors (125i) for 48 h. The mRNA level of APC was determined by RT-qPCR assay. (B) The level of p-β-catenin/β-catenin was examined by Western blot assay. (C) HCT116 cells were transfected with luciferase constructs and miR-125b mimics. The comparison of luciferase activity of wild-type (WT) and mutant (MUT) APC-3′UTR constructs was performed 36 h after transfection. Data was normalized to renilla activity. *P < 0.05 vs. negative control (NC). (D) Western blotting was performed to determine the expression of APC, active-β-catenin, β-catenin, c-Myc and TCF1. Bar graphs indicated the relative levels of these proteins normalized to β-actin. *P < 0.05 vs. negative control. (E, F) RT-qPCR was performed to examine the expression of miR-125b and APC mRNA in 14 pairs of CRC tissues and adjacent normal colorectal tissue. *P < 0.05 vs. normal group.
Figure 4
Figure 4. MiR-125b reduced the 5-FU-induced apoptosis in CRC cells.
(A) HCT116 and SW620 cells were transfected with 100 nM miR-125b mimics (125 m) for 24 h, then were treated with 5, 10 μM 5-FU or 25, 50 μM 5-FU for 72 h respectively. Cell viability was estimated by the MTT assay. (B) HCT116 and SW620 cells were transfected with 100 nM miR-125b mimics (125 m) or 200 nM siRNA of CXCR4 for 24 h, then the cells were treated with or without 25 μM or 50 μM 5-FU for 48 h respectively. Annexin V-PI double staining assay was performed to determine apoptotic cells using flow cytometry. Bar graphs indicated the percentage of apoptotic cells. Data represent mean ± SD of three experiments. *P < 0.05 vs. negative control (NC). (C) HCT116 and SW620 cells were treated as above, Western blotting was performed to analyze the expression of apoptotic proteins Bax, Bcl-2, PARP, caspase-3 and autophagic protein LC3 cleavage. Bar graphs indicated the relative levels of Bax/Bcl-2, PARP, cleaved-caspase 3/pro-caspase 3 and LC3-II/LC3-I normalized to β-actin. *P < 0.05 vs. vehicle control, #P < 0.05 vs. negative control (NC).
Figure 5
Figure 5. MiR-125b activated autophagic activity in CRC cells.
(A) HCT116 and SW620 cells were transfected with 100 nM miR-125b mimics (125 m) or inhibitors (125i) for 48 h. The expression of beclin-1 and cleaved LC3-II was examined by Western blot assay. Bar graphs indicated relative levels of LC3-II and Beclin-1normalized to β-actin. Data represent mean ± SD of three experiments. *P < 0.05 vs. negative control. (B) HCT116 and SW620 cells were co-transfected with GFP-LC3 plasmid and 100 nM miR-125b mimics for 48 h in the presence or absence of 5 mM 3-MA. Representative photographs were taken using a confocal microscopy (scale bar = 25 μm). Numbers of GFP-LC3 puncta per cell were counted (*P < 0.05 vs. negative control, #P < 0.05 vs. 125 m group, n = 10). Data represent mean ± SD of three experiments.
Figure 6
Figure 6. MiR-125b inhibited the 5-FU-induced apoptosis in the xenograft model in vivo.
HCT116 cells infected with lentiviral miR-125b (125 m) and negative control (NC) were injected subcutaneously into nude mice. When tumor volume reached 100 mm3, 5-FU (20 mg/kg) was injected intraperitoneally five times per week for two weeks. (A) Tumor volumes were measured twice per week and the dynamic changes were shown in curves. Data represent mean ± SD. CON represents a short form of vehicle control. (B) Tumor images were taken at the end of the experiments. RNA was extracted from xenograft tumors of NC-CON and 125m-CON groups to determine the expression of miR-125b expression by RT-qPCR assay. (C) Tumor weight and volume were determined after removal. Data represent mean ± SD, *P < 0.05 vs. negative control. (D) Representative images were shown to indicate the expression of E-cadherin, PCNA and Beclin-1 in different groups through immunohistochemistry assay(400 ×). Results were semi-quantified by image-pro plus 6 software and statistical analyses were performed. *P < 0.05 vs. negative control. (E) Protein lysates were extracted from xenograft tumor tissues to determine the expression of Bax, PARP, caspases and autophagic proteins beclin-1 and LC3-II by Western blot assay. Bar graphs indicated the relative levels of cleaved PARP, cleaved caspase-9, caspase-3, LC3-II and Beclin-1 normalized to β-actin. Data represent mean ± SD of three experiments. *P < 0.05 vs. negative control. CON represents a short form of vehicle control, 5-FU is a short form of 5-fluororacil.

References

    1. Nordlinger B. & Rougier P. Liver metastases from colorectal cancer: the turning point. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 20, 1442–1445 (2002). - PubMed
    1. Muller A. et al.. Involvement of chemokine receptors in breast cancer metastasis. Nature 410, 50–56 (2001). - PubMed
    1. Schimanski C. C. et al.. Effect of chemokine receptors CXCR4 and CCR7 on the metastatic behavior of human colorectal cancer. Clinical cancer research: an official journal of the American Association for Cancer Research 11, 1743–1750 (2005). - PubMed
    1. Zeelenberg I. S., Ruuls-Van Stalle L. & Roos E. The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases. Cancer research 63, 3833–3839 (2003). - PubMed
    1. Croker A. K. & Allan A. L. Cancer stem cells: implications for the progression and treatment of metastatic disease. Journal of cellular and molecular medicine 12, 374–390 (2008). - PMC - PubMed

Publication types

MeSH terms